Mon, August 29, 2022
Sun, August 28, 2022
Fri, August 26, 2022
Thu, August 25, 2022
Wed, August 24, 2022
Tue, August 23, 2022
Mon, August 22, 2022
Fri, August 19, 2022
Thu, August 18, 2022

Asthika Goonewardene Maintained (STRO) at Strong Buy with Decreased Target to $21 on, Aug 23rd, 2022

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-21-on-aug-23rd-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

- Click to Lock Slider
Asthika Goonewardene of Truist Securities, Maintained "Sutro Biopharma, Inc." (STRO) at Strong Buy with Decreased Target from $37 to $21 on, Aug 23rd, 2022.

Asthika has made no other calls on STRO in the last 4 months.



There are 2 other peers that have a rating on STRO. Out of the 2 peers that are also analyzing STRO, 0 agree with Asthika's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Asthika


  • Edward Tenthoff of "Piper Sandler" Maintained at Buy with Decreased Target to $14 on, Monday, May 23rd, 2022
  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $30 on, Wednesday, May 11th, 2022